[논문]Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review

Chah, Neysan; Jones, Mike; Milord, Steve; Al-Eryani, Kamal; Enciso, Reyes

doi:10.17245/jdapm.2021.21.5.413

Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review 원문보기

Journal of dental anesthesia and pain medicine, v.21 no.5, 2021년, pp.413 - 429

Chah, Neysan (Herman Ostrow School of Dentistry of USC) , Jones, Mike (Herman Ostrow School of Dentistry of USC) , Milord, Steve (Herman Ostrow School of Dentistry of USC) , Al-Eryani, Kamal (Division of Diagnostic Sciences, Herman Ostrow School of Dentistry of USC) , Enciso, Reyes (Division of Dental Public Health and Pediatric Dentistry, Herman Ostrow School of Dentistry of University of Southern California)

Abstract ▼ AI-Helper

Background: Migraine headaches are the second leading cause of disability worldwide and are responsible for significant morbidity, reduction in the quality of life, and loss of productivity on a global scale. The purpose of this systematic review and meta-analysis was to evaluate the efficacy of ketamine on migraines and other primary headache disorders compared to placebo and other active interventions, such as midazolam, metoclopramide/diphenhydramine, and prochlorperazine/diphenhydramine. Methods: An electronic search of databases published up to February 2021, including Medline via PubMed, EMBASE, Web of Science, and Cochrane Library, a hand search of the bibliographies of the included studies, as well as literature and systematic reviews found through the search was conducted to identify randomized controlled trials (RCTs) investigating ketamine in the treatment of migraine/headache disorders compared to the placebo. The authors assessed the risk of bias according to the Cochrane Handbook guidelines. Results: The initial search strategy yielded 398 unduplicated references, which were independently assessed by three review authors. After evaluation, this number was reduced to five RCTs (two unclear risk of bias and three high risk of bias). The total number of patients in all the studies was 193. Due to the high risk of bias, small sample size, heterogeneity of the outcomes reported, and heterogeneity of the comparison groups, the quality of the evidence was very low. One RCT reported that intranasal ketamine was superior to intranasal midazolam in improving the aura attack severity, but not duration, while another reported that intranasal ketamine was not superior to metoclopramide and diphenhydramine in reducing the headache severity. In one trial, subcutaneous ketamine was superior to saline in migraine severity reduction; however, intravenous (I.V.) ketamine was inferior to I.V. prochlorperazine and diphenhydramine in another study. Conclusion: Further double-blind controlled studies are needed to assess the efficacy of ketamine in treating acute and chronic refractory migraines and other primary headaches using intranasal and subcutaneous routes. These studies should include a long-term follow-up and different ketamine dosages in diagnosed patients following international standards for diagnosing headache/migraine.

주제어

참고문헌 (45)

1 Vincent M Wang S Olesen J Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition Cephalalgia 2018 38 1 211

상세보기
2 Kaniecki RG Levin AD Headache in the elderly DeKosky S.T. Asthana S. Handbook of Clinical Neurology, Vol. 167 (3rd series) 1st ed Elsevier B.V 2019 511 528
3 Goadsby PJ Primary headache disorders: Five new things Neurol Clin Pract 2019 9 233 240 31341711

상세보기
4 GBD 2016 Headache Collaborators Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet Neurol 2018 17 954 976 30353868

상세보기
5 Leonardi M Raggi A A narrative review on the burden of migraine: when the burden is the impact on people's life J Headache Pain 2019 20 41 31023226
6 Lipton RB Stewart WF Diamond S Diamond ML Reed M Prevalence and burden of migraine in the United States: data from the American Migraine Study II Headache 2001 41 646 657 11554952

상세보기
7 Burch R Rizzoli P Loder E The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies Headache 2018 58 496 505 29527677

상세보기
8 Jensen R Stovner LJ Epidemiology and comorbidity of headache Lancet Neurol 2008 7 354 361 18339350

상세보기
9 Cameron C Kelly S Hsieh SC Murphy M Chen L Kotb A Triptans in the acute treatment of migraine: a systematic review and network meta-analysis Headache 2015 55 221 235 26178694

상세보기
10 Craven R Ketamine Anaesthesia 2007 62 48 53 17937714
11 Green SM Rotbrock SG Lynch EL Ho M Harris T Hestdalen R Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases Ann Emerg Med 1998 31 688 697 9624307

상세보기
12 Sinner B Graf BM Shüttler J Schwilden H Modern Anesthetics. Handbook of Experimental Pharmacology, Volume 182 Berlin Springer-Verlag 2008 313 333
13 Zanos P Moaddel R Morris PJ Riggs LM Highland JN Georgiou P Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms Pharmacol Rev 2018 70 621 660 29945898

상세보기
14 Mayans L Walling A Acute migraine headache: treatment strategies Am Fam Physician 2018 97 243 251 29671521

상세보기
15 Friedman BW Hochberg ML Esses D Grosberg BM Rothberg D Bernstein B Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes Ann Emerg Med 2008 52 696 704 18387702

상세보기
16 Goldberg ME Domsky R Scaringe D Hirsh R Dotson J Sharaf I Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome Pain Physician 2005 8 175 179 16850072

상세보기
17 Guirimand F Dupont X Brasseur L Chauvin M Bouhassira D The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans Anesth Analg 2000 90 408 414 10648330

상세보기
18 Lauritsen C Mazuera S Lipton RB Ashina S Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series J Headache Pain 2016 17 106 27878523
19 The Cochrane Collaboration Higgins J Green S Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 Hoboken Wiley 2011
20 Cochran WG The combination of estimates from different experiments Biometrics 1954 10 101 129

상세보기
21 Higgins JP Thompson SG Quantifying heterogeneity in a meta-analysis Stat Med 2002 21 1539 1558 12111919

상세보기
22 Afridi SK Giffin NJ Kaube H Goadsby PJ A randomized controlled trial of intranasal ketamine in migraine with prolonged aura Neurology 2013 80 642 647 23365053

상세보기
23 Etchison AR Bos L Ray M McAllister KB Mohammed M Park B Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial West J Emerg Med 2018 19 952 960 30429927

상세보기
24 Zitek T Gates M Pitotti C Barlett A Patel J Rahbar A A comparison of headache treatment in the emergency department: prochlorperazine versus ketamine Ann Emerg Med 2018 71 369 377 29033296

상세보기
25 Benish T Villalobos D Love S Casmaer M Hunter CJ Summers SM The THINK (treatment of headache with intranasal ketamine) trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide J Emerg Med 2019 56 248 257 30910061

상세보기
26 Nicolodi M Sicuteri F Exploration of NMDA receptors in migraine: therapeutic and theoretic implications Int J Clin Pharmacol Res 1995 15 181 189 8835616

상세보기
27 Pomeroy JL Marmura MJ Nahas SJ Viscusi ER Ketamine infusions for treatment refractory headache Headache 2017 57 276 282 28025837

상세보기
28 Niesters M Martini C Dahan A Ketamine for chronic pain: risks and benefits Br J Clin Pharmacol 2014 77 357 367 23432384

상세보기
29 Messenger DW Murray HE Dungey PE van Vlymen J Sivilotti ML Subdissociative - dose ketamine versus fentanyl for analgesia during propofol procedural sedation: a randomized clinical trial Acad Emerg Med 2008 15 877 886 18754820

상세보기
30 Lee EN Lee JH The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis PLoS One 2016 11 e0165461 27788221

상세보기
31 Beaudoin FL Lin C Guan W Merchant RC Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial Acad Emerg Med 2014 21 1193 1202 25377395

상세보기
32 Carr DB Goudas LC Denman WT Brookoff D Staats PS Brennen L Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study Pain 2004 108 17 27 15109503

상세보기
33 Bilhimer MH Groth ME Holmes AK Ketamine for migraine in the emergency department Adv Emerg Nurs J 2020 42 96 102 32358422

상세보기
34 Todd KH A review of current and emerging approaches to pain management in the emergency department Pain Ther 2017 6 193 202 29127600
35 Motov S Rosenbaum S Vilke GM Nakajima Y Is there a role for intravenous subdissociative-dose ketamine administered as an adjunct to opioids or as a single agent for acute pain management in the emergency department? J Emerg Med 2016 51 752 757 27693070

상세보기
36 Orr SL Friedman BW Christie S Minen MT Bamford C Kelley NE Management of adults with acute migraine in the emergency department: the american headache society evidence assessment of parenteral pharmacotherapies Headache 2016 56 911 940 27300483

상세보기
37 Cohen SP Bhatia A Buvanendran A Schwenk ES Wasan AD Hurley RW Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the american society of regional anesthesia and pain medicine, the american academy of pain medicine, and the american society of anesthesiologists Reg Anesth Pain Med 2018 43 521 546 29870458
38 Naeem F Schramm C Friedman BW Emergent management of primary headache: a review of current literature Curr Opin Neurol 2018 31 286 290 29461426

상세보기
39 Rashed A Mazer-Amirshahi M Pourmand A Current approach to undifferentiated headache management in the emergency department Curr Pain Headache Rep 2019 23 26 30868276

상세보기
40 Schwenk ES Dayan AC Rangavajjula A Torjman MC Hernandez MG Lauritsen CG Ketamine for refractory headache: a retrospective analysis Reg Anesth Pain Med 2018 43 875 879 29923953
41 Turner AL Shandley S Miller E Perry MS Ryals B Intranasal ketamine for abortive migraine therapy in pediatric patients: a single-center review Pediatr Neurol 2020 104 46 53 31902550

상세보기
42 Motov S Mai M Pushkar I Likourezos A Drapkin J Yasavolian M A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED Am J Emerg Med 2017 35 1095 1100 28283340
43 Olesen J Bousser MG Diener HC Dodick D First M Goadsby PJ The International Classification of Headache Disorders. 2nd edition. ICHD-2 Cephalalgia 2004 24 1 160
44 Olesen J Bendtsen L Dodick D Ducros A Evers S First M The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia 2013 33 629 808 23771276

상세보기
45 Olesen J Bes A Kunkel R Lance JW Nappi G Pfaffenrath V Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society Cephalalgia 1988 8 Suppl 7 1 96

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (45)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트